Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

228
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
228
Randomized Experiments01:13

Randomized Experiments

7.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.1K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

589
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
589
Crossover Experiments01:16

Crossover Experiments

2.9K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.9K
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

85
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
85
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

122
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
122

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Appearance of Pancreas Predictive of Cancer Presence: Utility of Computed Tomography Volumetry.

Cancers·2026
Same author

Causal Rule Ensemble Approach for Multi-Arm Data.

Statistics in medicine·2026
Same author

Adverse Events of EUS-Guided Biliary Drainage for Malignant Biliary Obstruction: A Large Multicenter Study.

Journal of hepato-biliary-pancreatic sciences·2025
Same author

Survival causal rule ensemble method considering the main effect for estimating heterogeneous treatment effects.

Statistics in medicine·2024
Same author

Utilizing Clinical Transformation Criteria for Prognostic Stratification in Follicular Lymphoma Prior to Initial Immunochemotherapy.

Hematology reports·2024
Same author

Causal rule ensemble method for estimating heterogeneous treatment effect with consideration of prognostic effects.

Statistical methods in medical research·2024

Related Experiment Video

Updated: Jul 27, 2025

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.7K

Rule ensemble method with adaptive group lasso for heterogeneous treatment effect estimation.

Ke Wan1, Kensuke Tanioka2, Toshio Shimokawa1

  • 1Department of Medical Data Science, Wakayama Medical University, Wakayama, Japan.

Statistics in Medicine
|June 7, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces an interpretable machine learning method for estimating heterogeneous treatment effects (HTE) from complex real-world data. The novel approach enhances prediction accuracy while maintaining model interpretability for precision medicine applications.

Keywords:
heterogeneous treatment effectinterpretabilitypotential outcomerule ensembles

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K
The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

5.9K

Related Experiment Videos

Last Updated: Jul 27, 2025

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.7K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K
The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

5.9K

Area of Science:

  • Computational biology
  • Data science
  • Medical informatics

Background:

  • Precision medicine increasingly relies on real-world data to understand treatment effects.
  • Estimating heterogeneous treatment effects (HTE) is challenging due to data complexity and inherent individual variability.
  • Existing machine learning (ML) methods for HTE often lack interpretability due to their 'black-box' nature.

Purpose of the Study:

  • To develop an interpretable machine learning method for estimating heterogeneous treatment effects (HTE).
  • To address the limitations of current ML models that hinder direct interpretation of treatment effect drivers.
  • To improve the accuracy and interpretability of HTE estimation in precision medicine.

Main Methods:

  • Modification of the RuleFit algorithm to estimate HTE within the potential outcome framework.
  • Development of a novel ML approach combining accuracy and interpretability for HTE analysis.
  • Application of the proposed method to the ACTG 175 HIV clinical dataset.

Main Results:

  • The proposed modified RuleFit method demonstrated high prediction accuracy compared to existing approaches.
  • The method successfully generated an interpretable model, revealing relationships between patient characteristics and treatment effects.
  • Ensemble of rules provided direct insights into individual feature impacts on treatment outcomes.

Conclusions:

  • The developed ML method effectively estimates HTE with both high accuracy and interpretability.
  • This approach facilitates a deeper understanding of treatment effect variations in real-world data.
  • The findings support the application of interpretable ML in advancing precision medicine.